image credit: Adobe Stock

Applied StemCell Expands Cell and Gene Therapy Manufacturing Facility

August 31, 2022

Applied StemCell, Inc. (ASC), a cell and gene therapy CRO/CDMO focused on supporting the research community and biotechnology industry for their needs in developing and manufacturing cell and gene products, is expanding its current good manufacturing (cGMP) facility. ASC has successfully carried out cell banking and product manufacturing projects in its current cGMP suite and is now set on building 4 additional cGMP cleanrooms, cryo-storage space, and a process development and QC/QA space.

Read More on Contract Pharma